Ad
related to: modernathecountyoffice.com has been visited by 1M+ users in the past month
Search results
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 6 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Moderna mRNA candidate chosen for FDA rare disease therapy acceleration program
Seeking Alpha· 3 days agoThe FDA selects Moderna's mRNA therapeutic mRNA-3705 for a pilot program to accelerate development...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 3 days agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support ...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 6 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 7 days agoOn Friday, Moderna Inc. (Nasdaq: MRNA) notched its second-ever FDA product approval, this time for...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 2 days agoOn Friday, Moderna Inc. MRNA announced that it has submitted an FDA application for review of its...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 6 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 3 days agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 6 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 6 days agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...